1. Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

   • Federico Pea
   • Pierluigi Viale

   Current Opinion 13 September 2012 Pages: 147 - 152

   

2. Antiretroviral Therapy

   • Sarah M. McCabe
   • Qing Ma
   • Gene D. Morse

   Review Article 13 September 2012 Pages: 153 - 172

   

3. Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

   • Arantxazu Isla
   • Alicia Rodríguez-Gascón
   • José Luis Pedraz

   Original Research Article 13 September 2012 Pages: 173 - 180

   

4. Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis Data

   • Claire Dahyot
   • Sandrine Marchand
   • William Couet

   Original Research Article 13 September 2012 Pages: 181 - 189

   

5. In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

   • Evelyn D. Lobo
   • Richard F. Bergstrom
   • Mary Pat Knadler

   Original Research Article 13 September 2012 Pages: 191 - 202

   

6. Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery

   • Wolfgang Mueck
   • Bengt I. Eriksson
   • Alexander G. G. Turpie

   Original Research Article 13 September 2012 Pages: 203 - 216